Principal Scientist, Paul Barr, shares his takeaways from the recent Future Cannabis Strategies...
Emerging pharmaceutical sectors to watch in 2023: Pyschedelics
Broughton CEO, Chris Allen, looks at the emerging field of psychedelic pharmaceutical drug development and shares some of the best articles he read in 2022.
All articles
In this blog, we will look at some of the key challenges facing animal health manufacturers and...
Broughton takes a look at the FDA’s recent announcement that it is developing a regulatory...
Increasing patient access to cannabis-based medicines
Trends in the Next Generation Nicotine Product Industry: 2022
In recent years, a growing number of countries have legalized cannabis for medicinal purposes,...
What does 2023 have in store for the next-generation nicotine sector?
Day 1 of DDL opened with Federico Lavorini’s history and future of drug delivery, and it was a...
The 3rd Annual Extractables and Leachables (E&L) Conference
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
